$1.08
0[0.00%]
At close: Apr 26
$1.08
0[0.00%]
After Hours: 8:34AM EDT
Oncolytics Biotech
(NASDAQ:ONCY)Oncolytics Biotech Stock (NASDAQ:ONCY), Analyst Ratings, Price Targets, Predictions
Oncolytics Biotech Inc has a consensus price target of $5, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, HC Wainwright & Co., and HC Wainwright & Co. on April 4, 2024, March 8, 2024, and February 14, 2024. With an average price target of $4.33 between Raymond James, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 301.23% upside for Oncolytics Biotech Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
HC Wainwright & Co.
Canaccord Genuity
JonesTrading
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Oncolytics Biotech
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 177.78% | Raymond James | Rahul Sarugaser | → $3 | Initiates | → Outperform | Get Alert |
| 03/08/2024 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | HC Wainwright & Co. | Patrick Trucchio | $5 → $5 | Maintains | Buy | Get Alert |
| 02/14/2024 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
| 01/19/2024 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
| 01/04/2024 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | HC Wainwright & Co. | Patrick Trucchio | $15 → $5 | Maintains | Buy | Get Alert |
| 08/16/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 1288.89% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 1288.89% | HC Wainwright & Co. | Patrick Trucchio | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/23/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | Canaccord Genuity | John Newman | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 1288.89% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 1288.89% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 733.33% | JonesTrading | Soumit Roy | → $9 | Initiates | → Buy | Get Alert |
| 03/14/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 1288.89% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 362.96% | Canaccord Genuity | John Newman | $6 → $5 | Maintains | Buy | Get Alert |
| 10/06/2022 | ONCY | Buy Now | Oncolytics Biotech | $1.08 | 177.78% | Maxim Group | Jason McCarthy | → $3 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Oncolytics Biotech (ONCY)?
The latest price target for Oncolytics Biotech (NASDAQ: ONCY) was reported by Raymond James on April 4, 2024. The analyst firm set a price target for $3.00 expecting ONCY to rise to within 12 months (a possible 177.78% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Oncolytics Biotech (ONCY)?
The latest analyst rating for Oncolytics Biotech (NASDAQ: ONCY) was provided by Raymond James, and Oncolytics Biotech initiated their outperform rating.
When was the last upgrade for Oncolytics Biotech (ONCY)?
There is no last upgrade for Oncolytics Biotech.
When was the last downgrade for Oncolytics Biotech (ONCY)?
There is no last downgrade for Oncolytics Biotech.
When is the next analyst rating going to be posted or updated for Oncolytics Biotech (ONCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oncolytics Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oncolytics Biotech was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Oncolytics Biotech (ONCY) correct?
While ratings are subjective and will change, the latest Oncolytics Biotech (ONCY) rating was a initiated with a price target of $0.00 to $3.00. The current price Oncolytics Biotech (ONCY) is trading at is $1.08, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.